BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9432039)

  • 1. Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16beta, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT-PCR using a polycompetitive internal standard.
    Schwaller J; Pabst T; Bickel M; Borisch B; Fey MF; Tobler A
    Br J Haematol; 1997 Dec; 99(4):896-900. PubMed ID: 9432039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
    Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
    Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.
    Watanabe G; Pena P; Shambaugh GE; Haines GK; Pestell RG
    Brain Res Dev Brain Res; 1998 Jun; 108(1-2):77-87. PubMed ID: 9693786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclin-dependent kinase inhibitors p18INK4c and p19INK4d are highly expressed in CD34+ progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells.
    Tschan MP; Peters UR; Cajot JF; Betticher DC; Fey MF; Tobler A
    Br J Haematol; 1999 Sep; 106(3):644-51. PubMed ID: 10468852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of p16INK4a, p15INK4b, p21WAF1/Clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) ].
    Kapelko-Słowik K; Wołowiec D; Sedek K; Jaźwiec B; Urbaniak-Kujda D; Kuliczkowski K
    Pol Arch Med Wewn; 2002 Sep; 108(3):849-53. PubMed ID: 12600181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential role for p15(Ink4b) and p57(Kip2) in liver development.
    Awad MM; Sanders JA; Gruppuso PA
    FEBS Lett; 2000 Oct; 483(2-3):160-4. PubMed ID: 11042273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
    Chellappan SP; Giordano A; Fisher PB
    Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
    Korshunov A; Shishkina L; Golanov A
    Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
    Zindy F; Quelle DE; Roussel MF; Sherr CJ
    Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours.
    Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J
    Int J Cancer; 2000 Feb; 85(3):370-5. PubMed ID: 10652429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.